Board - team
|
|
Göran Grosskopf
Chairman ColoPlus AB
Jur. Phd, Ekon.dr. h.c. Professor
Chairman Ingka Holding BV and Peab AB
(former Chairman of Tetra Laval Group)
As chairman of the Tetra Laval Group, which is a dominant sponsor of school milk programs in the third world, I have seen what nutrition can mean to change to a better life for children. Colostrum further enhances the well being of children by also stopping diarhea in addition to improving nutrition.
It is an important mission to everyone to do the utmost to improve the quality of life of people in the third world and not the least HIV infected people. And this is what ColoPlus can do. |
|
|
Conny Hagman
Managing Director ColoPlus AB
MSc Econ. (former deputy chairman TKF,
Swedish Technology Transfer Ass.)
As a teamleader and senior consultant working with technology transfer, I find this mission a challenge with a very special human content, of great concern for many people in the third world.
Our ColoPlus team joins highly motivated individuals with selected scientific competence and experience.
Member of Biotech Builders |
|
|
Margareta Nilsson
Med.dr. hc, Ekon.dr. hc and
Boardmember of The Crafoord Foundation
In my position contacts with innovations are central. I support ColoPlus with great entusiasm for the proven potential of helping people suffering from HIV/AIDS complications.
This innovation comes from nature itself.
Far from research, I also run a farm with
milking cows and know the importance of
colostrum for bringing the newborn calf
passive immunisation. |
|
|
Ingemar Ihse
MD, PhD, Professor
(former medical director
Lund University Hospital)
I am a surgeon with a main clinical and research interest in abdominal diseases. I became early fascinated by the concept of imitating the potential of nature in medical treatment.
Utilizing bovine colostrum to make life easier for patients suffering from aids is a promising example of this kind of thinking.
|
|
|
Claes-Henrik Florén
MD, PhD, Professor
Gastroenterology
Lund University Hospital
Diarrhoeal diseases can be life-threatening.
I know it all too well from my experience working as a clinical gastroenterologist. Colostrum protects the newly born from devastating diarrhoeas.
It is rewarding to see that colostrum can offer relief also to adults with diarrhoeal diseases.
|
|
|
Lidia Elfstrand
Ph.D. Pharmaceutical Technology,
MSc Food Technology
Bovine colostrum is a generous gift from nature but also a delicate material. To collect and use it with care, and, finally, to bring it to HIV suffering people to improve immune misbalance and prevent malnutrition is a task lying close to my heart.
I use all my knowledge and enthusiasm to make it work optimal.
|
|
 |
Kris Nygren
ColoPlus AB, New Zealand office
BSc Business Administration
Innovation Management
I have followed the development of ColoPlus for several years, fascinated with and admiring the scientific rigor applied in product development and clinical testing. As a part of the ColoPlus team, I look forward to applying my core expertise in business development and commercialisation of innovations. |
|
 |
Tor Ekman
MD, PhD, Associate Professor
Department of Oncology
Sahlgrenska University Hospital
As a consultant in oncology I meet daily patients affected by side effects of chemotherapy or radiation therapy. One of the most distressing and prevalent side effects is derived from the injury to the intestinal tract.
If we can demonstrate beneficial effects of ColoPlus ONCARE this would have a tremendous impact on the patient´s quality of life during therapy as well as on resource utilization. Full statement | |
HIV is a major problem in many countries
|
